InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Menzel Garry E, Chief Executive Officer. Insider active across 1 companies, notably TCR2 THERAPEUTICS INC.. In total, 3 reports have been recorded. The latest transaction was filed on 28 February 2022 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations3 total
€2,9311,425 shares@ €2.057122.3% of flow
Common Stock
SEC:0001209191-22-020025:0·
€5,095422 shares@ €12.0742100.0% of flow
Common Stock
SEC:0001209191-21-069050·
€5,095422 shares@ €12.074238.8% of flow
Common Stock
SEC:0001209191-21-069050:0·
3 of 3 declarations
About Menzel Garry E
Menzel Garry E is the President & CEO of TCR2 THERAPEUTICS INC. He leads the company's operations and strategy, focusing on the development of innovative therapies. Garry has significant experience in the biotechnology sector, contributing to improving healthcare.
